Definition of Diabetic Renal Disease in Insulin-Dependent Diabetes Mellitus Based on Renal Function Tests

  • Carl Erik Mogensen
Part of the Topics in Renal Medicine book series (TIRM, volume 6)

Abstract

Defining renal disease and renal involvement in diabetes is not an easy task, mainly because of the wide range of charges seen. The different degree of abnormalities, even with the same duration of disease, seemingly same quality of long-term metabolic control, and the same type of diabetes, is indeed striking [1–4].

Keywords

Diabetic Nephropathy Renal Involvement Proliferative Diabetic Retinopathy Urinary Albumin Excretion Albumin Excretion Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thomsen OF, Andersen AR, Christiansen JS, Deckert T: Renal changes in long-term type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material. Diabetologia 26: 361–365, 1984.PubMedCrossRefGoogle Scholar
  2. 2.
    Osterby R: Structural changes in the diabetic kidney. Clin Endocrinol Metab 15: 733–751, 1986.PubMedCrossRefGoogle Scholar
  3. 3.
    Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC: Structural—functional relationships in diabetic nephropathy. J Clin Invest 74: 1143–1155, 1984.PubMedCrossRefGoogle Scholar
  4. 4.
    Ellis EN, Steffes MW, Goetz FC, Sutherland DER, Mauer SM: Glomerular filtration surface in type I diabetes mellitus. Kidney Int 29: 889–894, 1986.PubMedCrossRefGoogle Scholar
  5. 5.
    Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32: 64–78, 1983.PubMedGoogle Scholar
  6. 6.
    Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31: 673–689, 1987.PubMedCrossRefGoogle Scholar
  7. 7.
    Viberti GC, Mackintosh D, Bilous RW, Rickup JC, Keen H: Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of gglycaemia. Kidney Int 21: 714–720, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Viberti GC, Wiseman MJ: The kidney in diabetes:Csignificance of the early abnormalities. J Clin Endocrinol Metab 15: 753–782, 1986.CrossRefGoogle Scholar
  9. 9.
    Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430 1432, 1982.Google Scholar
  10. 10.
    Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T: Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Christensen CK, Mogensen CE: The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 2: 97–102, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Feldt-Rasmussen B, Mathesen E, Deckert T: Effect of two years of strict metabolic control on the progession of incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304, 1986.PubMedCrossRefGoogle Scholar
  14. 14.
    Mogensen CE: Microalbuminuria and kidney function: notes on methods, interpretation, and classification. In: Clarke WL, Lamer J, Pohl SL (eds) Methods in diabetes research, vol 2: clinical methods. New York: John Wiley and Sons, 1986.Google Scholar
  15. 15.
    Damsgaard EM, Mogensen CE: Microalbuminuria in patients with occult fasting hyperglycemia and in known type 11 diabetics: an epidemiological study. Diabetic Med 3: 430–435, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Mogensen CE: Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest 28: 183–193, 1971.PubMedCrossRefGoogle Scholar
  17. 17.
    Mogensen CE, Vittinghus E: Urinary albumin excretion during exercise in juvenile diabetes: a provocation test for early abnormalities. Scand J Clin Lab Invest 35: 295–300, 1975.PubMedCrossRefGoogle Scholar
  18. 18.
    Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefbvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC: Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9: 85–96, 1985–1986.Google Scholar
  19. 19.
    Christiansen JS: Glomerular hyperfiltration in diabetes. Diabetic Med 2: 235–240, 1985.PubMedCrossRefGoogle Scholar
  20. 20.
    Christensen CK: Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise. Kidney Int 25: 819–823, 1984.PubMedCrossRefGoogle Scholar
  21. 21.
    Mogensen CE, Christensen CK: Blood pressure changes and renal function changes in incipient and overt diabetic nephropathy. Hypertension 7:11–64-II-68, 1985.Google Scholar
  22. 22.
    Wiseman M, Viberti GC, Mackintosh D, Jarrett RJ, Keen H: Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401–405, 1984.PubMedCrossRefGoogle Scholar
  23. 23.
    Barnett AH, Dallinger K, Jennings R, Fletcher J, Odugbesan O: Microalbuminuria and diabetic retinopathy. Lancet 1: 53–54, 1985.PubMedCrossRefGoogle Scholar
  24. 24.
    Vigstrup J, Mogensen CE: Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria. Acta Ophthalmol 63: 530–534, 1985.Google Scholar
  25. 25.
    Feldt-Rasmussen B: Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282–286, 1986.PubMedCrossRefGoogle Scholar
  26. 26.
    Parving HH, Noer I, Deckert T, Evrin PE, Nielsen SL, Lyngsoe J, Mogensen CE, Rorth M, Svendsen PA, Trap Jensen J, Lassen NA: The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 12: 161–166, 1976.PubMedCrossRefGoogle Scholar
  27. 27.
    Christensen CK: Rapidly reversible albumin and 13–2-microglobulin hyperexcretion in recent severe essential hypertension. J Hypertension 1: 45–51, 1983.CrossRefGoogle Scholar
  28. 28.
    Viberti GC, Mogensen CE, Keen H, Jacobsen FK, Jarrett RJ, Christensen CK: Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest 42: 147–152, 1982.PubMedCrossRefGoogle Scholar
  29. 29.
    Mauer SM, Steffes MW, Ellis EN, Brown DM: Can the insulin-dependent diabetic patient be managed without kidney biopsy? In: Robinson RR, Dennis VW, Ferris TF, Glassock RJ, Kokko JP, Tisher CC (eds) Nephrology, vol 2: proceedings of the 9th international congress of nephrology. New York: Springer-Verlag, 1984.Google Scholar
  30. 30.
    Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688, 1982.CrossRefGoogle Scholar
  31. 31.
    Bröchner-Mortensen J: Current status on assessment and measurement of gomerular filtration rate. Clin Physiol 5: 1–17, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Mogensen CE: Early diabetic renal involvement and nephropathy. The Diabetes Annual 3: 306–324, 1987. Alberti KGMM, Krall LP (eds), Elsevier Science Publishers. Amsterdam, New York, Oxford.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Carl Erik Mogensen

There are no affiliations available

Personalised recommendations